Komodo Health Appoints Miles Ennis to Chief Operating Officer

Technology veteran to scale operations as AI healthcare analytics platform accelerates market expansion

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced the appointment of Miles Ennis to Chief Operating Officer (COO). Ennis, who joined Komodo Health as Chief Revenue Officer in July 2024, will expand his leadership role to oversee the company's operational strategy and execution across all business functions while continuing to drive commercial excellence.

The announcement comes as Komodo Health scales to meet intense demand for its breakthrough AI innovations such as Marmot™ — its proprietary AI engine that empowers Life Sciences organizations to answer complex questions with unprecedented speed and rigor — which require enhanced operational capabilities to support rapid market expansion and platform deployment across enterprise customers.

Since joining Komodo, Ennis has been a driving force behind the company's success, leading the revenue organization to consistently exceed commercial objectives while building strategic partnerships that have expanded Komodo’s market reach. His commercial leadership has established a groundbreaking partnership with Nasdaq that has brought healthcare intelligence to the Financial Services industry for the first time. This partnership enables hedge fund, private equity, and venture capital firms to make more informed investment decisions with insights from Komodo’s Healthcare Map®, which tracks the healthcare journeys of 330+ million patients in the U.S.

“Miles's impact has been profound and immediate,” said Web Sun, President and Co-Founder of Komodo Health. “In his time as CRO, he has not only delivered outstanding commercial results, he has also demonstrated the strategic vision and operational rigor that has elevated our organization. His promotion to COO is a natural progression that positions him to scale our operations and deliver unparalleled value to our customers.”

As Chief Operating Officer, Ennis will lead company-wide operations spanning Revenue, Services, Account Management, Customer Success, Consulting, and Strategic Programs while driving improved cross-functional execution across Product Engineering, Marketing, and Technology. He will be responsible for aligning Komodo’s people, processes, and platforms to accelerate growth, scale delivery, and strengthen the company’s position as a market leader in healthcare analytics AI.

“I'm honored to take on this expanded role at such an exciting time in Komodo’s evolution,” Ennis said. “My focus will be on building the operational infrastructure needed to scale our AI platform across global markets while maintaining the speed and precision our customers expect. As we accelerate Marmot deployment and expand into new market segments, operational excellence is even more critical to delivering on our mission of reducing disease burden.”

Ennis brings more than 20 years of experience in scaling global teams and driving digital transformation at major technology companies, including Talkdesk, IBM, Cisco, and Aspen Technology. His expertise in complex commercial operations and strategic growth has been instrumental in Komodo’s continued market expansion.

About Komodo Health

Komodo Health is the leader in healthcare intelligence, building the foundational AI that is powering the future of how Life Sciences and healthcare organizations discover, develop, and deliver patient care. By deploying Marmot, its proprietary AI engine, across its Healthcare Map, the industry’s most authoritative and highest-fidelity platform for real-world de-identified patient insights, Komodo is ending the era of slow, fragmented analyses. Komodo’s healthcare-native AI platform makes it possible to answer complex questions with the speed and rigor required to accelerate critical decisions across the product life cycle — from trial design to launch strategy to post-market evidence generation — to ultimately reduce the burden of disease. For more information, visit www.komodohealth.com.